A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Exelixis
Incyte Corporation
Alaunos Therapeutics
Jazz Pharmaceuticals
Istari Oncology, Inc.
BioMimetix JV, LLC
Regeneron Pharmaceuticals
Servier
Basilea Pharmaceutica
Celgene
Istari Oncology, Inc.
Candel Therapeutics, Inc.
Lumos Pharma
Exelixis
Novartis
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Eisai Inc.
Novartis
TVAX Biomedical
TVAX Biomedical
Bristol-Myers Squibb
Karyopharm Therapeutics Inc
Medicenna Therapeutics, Inc.
Eisai Inc.
Boston Scientific Corporation
Celgene
Five Prime Therapeutics, Inc.
Celgene
Hoffmann-La Roche
Pfizer
Diffusion Pharmaceuticals Inc
Merck Sharp & Dohme LLC
MedImmune LLC
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Isarna Therapeutics GmbH
GE Healthcare
INSYS Therapeutics Inc
Pfizer
Novartis